Hanson & Doremus Investment Management Novartis Ag Transaction History

Hanson & Doremus Investment Management

  • $794 Million
  • Q3 2025

A detailed history of Hanson & Doremus Investment Management transactions in Novartis Ag stock. As of the latest transaction made, Hanson & Doremus Investment Management holds 674 shares of NVS stock, worth $87,795. This represents 0.01% of its overall portfolio holdings.

Number of Shares
674
Previous 625 7.84%
Holding current value
$87,795
Previous $76,000 13.16%
% of portfolio
0.01%
Previous 0.01%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 15, 2025
BUY
$113.5 - $129.73 $5,561 - $6,356
49 Added 7.84%
674 $86,000
Q2 2025

Jul 17, 2025
SELL
$101.96 - $121.01 $397,949 - $472,302
-3,903 Reduced 86.2%
625 $76,000
Q1 2025

Apr 17, 2025
BUY
$97.14 - $115.57 $379,137 - $451,069
3,903 Added 624.48%
4,528 $505,000
Q3 2024

Oct 17, 2024
SELL
$106.13 - $120.89 $12,204 - $13,902
-115 Reduced 15.54%
625 $71,000
Q1 2023

Apr 18, 2023
SELL
$80.03 - $92.81 $312,357 - $362,237
-3,903 Reduced 84.06%
740 $68,000
Q4 2022

Jan 18, 2023
BUY
$75.55 - $92.52 $290,263 - $355,461
3,842 Added 479.65%
4,643 $421,000
Q3 2022

Oct 20, 2022
SELL
$74.61 - $87.26 $10,221 - $11,954
-137 Reduced 14.61%
801 $61,000
Q2 2022

Jul 19, 2022
SELL
$80.52 - $93.75 $2,737 - $3,187
-34 Reduced 3.5%
938 $79,000
Q1 2022

Apr 22, 2022
BUY
$80.11 - $90.62 $9,212 - $10,421
115 Added 13.42%
972 $85,000
Q3 2021

Oct 21, 2021
SELL
$81.78 - $95.14 $17,909 - $20,835
-219 Reduced 20.35%
857 $70,000
Q2 2021

Jul 22, 2021
SELL
$85.24 - $94.15 $317,689 - $350,897
-3,727 Reduced 77.6%
1,076 $94,000
Q1 2021

May 03, 2021
BUY
$83.5 - $98.47 $3,590 - $4,234
43 Added 0.9%
4,803 $411,000
Q4 2020

Feb 01, 2021
BUY
$78.07 - $94.43 $287,609 - $347,880
3,684 Added 342.38%
4,760 $449,000
Q2 2020

Jul 17, 2020
SELL
$80.93 - $91.1 $297,094 - $334,428
-3,671 Reduced 77.33%
1,076 $94,000
Q1 2020

Apr 24, 2020
BUY
$70.67 - $99.01 $270,171 - $378,515
3,823 Added 413.74%
4,747 $391,000
Q1 2019

Apr 23, 2019
BUY
$75.32 - $86.15 $16,495 - $18,866
219 Added 31.06%
924 $0
Q2 2018

Aug 08, 2018
SELL
$64.91 - $73.36 $266,325 - $300,996
-4,103 Reduced 85.34%
705 $53,000
Q1 2018

May 10, 2018
BUY
$70.39 - $84.15 $288,810 - $345,267
4,103 Added 581.99%
4,808 $389,000
Q3 2017

Oct 26, 2017
BUY
$74.14 - $77.27 $52,268 - $54,475
705
705 $0

Others Institutions Holding NVS

# of Institutions
1,560
Shares Held
136M
Call Options Held
1.72M
Put Options Held
1.7M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $280B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Hanson & Doremus Investment Management Portfolio

Follow Hanson & Doremus Investment Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hanson & Doremus Investment Management, based on Form 13F filings with the SEC.

News

Stay updated on Hanson & Doremus Investment Management with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email